May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Expression of CCN Family Proteins, CTGF, CYR61 and NOV in the Human Cornea
Author Affiliations & Notes
  • W.E. Philipp
    Department of Ophthalmology, Medical University of Innsbruck, Innsbruck, Austria
  • L.E. Speicher
    Department of Ophthalmology, Medical University of Innsbruck, Innsbruck, Austria
  • Footnotes
    Commercial Relationships  W.E. Philipp, None; L.E. Speicher, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5041. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.E. Philipp, L.E. Speicher; Expression of CCN Family Proteins, CTGF, CYR61 and NOV in the Human Cornea . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5041.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Members of the CCN family of matricellular proteins are multifunctional growth factors representing a novel class of extracellular matrix–associated signalling molecules which are ligands of multiple integrin receptors. Several studies demonstrated that members of the CCN family are involved in the control of cell adhesion, chemotaxis, cell migration and cell proliferation. In particular, it was demonstrated that CTGF, CYR61 and NOV are potent angiogenic factors. In addition, CTGF was shown to possess strong fibrotic activity being involved in wound healing and several fibrotic diseases. The aim of the present study was to investigate whether CNN proteins are expressed in the normal cornea and whether their expression is increased in various corneal diseases.

Methods: : 20 inflamed and vascularized corneal buttons and 6 non inflamed corneas were obtained at the time of penetrating keratoplasty in patients with various corneal diseases. Immunohistochemistry was performed using the streptavidin–biotin–peroxidase method and highly specific antibodies against CTGF, CYR61 and NOV. 5 normal human corneas served as control.

Results: : In normal and non inflamed corneas CTGF and CYR61 were strongly expressed on epithelial cells and moderately on keratocytes and corneal endothelial cells while NOV was moderately expressed on epithelial cells. In addition, NOV and CTGF were also moderately expressed on endothelial cells of limbal vessels. In inflamed and vascularized corneas positive immunostaining of NOV and CTGF was also found in endothelial cells of of newly formed vessels in the stroma and the expression of CTGF and CYR61 was increased on keratocytes/fibroblasts particularly at sites of scar tissue or inflammation.

Conclusions: : The results of the present study demonstrate that CTGF, CYR61 and NOV are expressed in normal corneas. The expression of these CCN proteins on vascular endothelial cells in diseased corneas strongly suggest an important role of these molecules in corneal neovascularization. Since immunostaining of CTGF and CYR61 was increased on keratocytes/fibroblasts in scar tissue, both molecules may be involved in tissue remodeling, scar formation and fibrosis.

Keywords: cornea: clinical science • wound healing • neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×